Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Employer
- Institute for bioengineering of Catalonia, IBEC
- Technical University of Cluj-Napoca
- Technical University of Denmark
- University of Nottingham
- ; University of Surrey
- Empa
- Leiden University; yesterday published
- National Renewable Energy Laboratory NREL
- Nature Careers
- Radboud University
- The Ohio State University
- The University of Chicago
- UNIVERSITY OF HELSINKI
- Universitat de Barcelona
- University of British Columbia
- University of Utah
- Utrecht University
- ; Swansea University
- CNRS
- Charles University, Faculty of Pharmacy in Hradec Kralove
- Crohn’s & Colitis Australia IBD PhD Scholarship
- Delft University of Technology (TU Delft)
- Delft University of Technology (TU Delft); 17 Oct ’25 published
- ETH Zürich
- Ecole Polytechnique Federale de Lausanne - EPFL
- Faculdade de Ciências e Tecnologia
- Friedrich Schiller University Jena •
- Hebrew University of Jerusalem
- Instituto de Investigação e Inovação em Saúde da Universidade do Porto (i3S)
- KNAW
- Linköping University
- Monash University
- Multiple
- NORTHUMBRIA UNIVERSITY
- SciLifeLab
- TU Darmstadt
- The Institute of Cancer Research
- The International Institute of Molecular Mechanisms and Machines Polish Academy of Sciences
- The University of British Columbia (UBC)
- The University of Edinburgh;
- The University of Manchester;
- UCT Prague
- UNIVERSITATEA DE MEDICINA SI FARMACIE IULIU HATIEGANU
- University of Amsterdam (UvA)
- University of Amsterdam (UvA); Amsterdam
- University of Bergen
- University of California
- University of California Davis
- University of East Anglia
- University of Exeter
- University of Groningen
- University of Hertfordshire
- University of Newcastle
- University of Twente (UT)
- Utrecht University; today published
- 45 more »
- « less
-
Field
-
of drug resistance in cancer" under the guidance of Prof. Trevor Graham at the ICR. Please see https://www.icr.ac.uk/study-and-careers/phds-at-the-icr/our-phd-projects/detail/new-strategies-for-exploiting
-
), patent applications and commercialisation (e.g. UoE spinout, MitoRx Therapeutics ). Here, you will design, synthesise and characterise novel potential drug structures to target intracellular structures
-
to undertake a 4-year PhD research project whilst enhancing professional development and research skills through a comprehensive training programme. You will join a vibrant community of world-leading researchers
-
microchannel manifold ensures precise drug delivery to various zones of the denture and the underlying gingiva and mucosa. Finally, by designing and implementing intelligent control system to automate the entire
-
internships of students of the Master’s programs from Pharmacy and/or Bio-Pharmaceutical Sciences; Follow PhD courses based on an individual training and supervision plan. What you bring This position is a good
-
of medicines from the design phase onwards. It should integrate awareness and risk-benefit considerations. Key responsibilities Complete a PhD thesis within the official appointment duration of four year
-
. The research programme is directed at several epidemiological, therapeutic, and policy aspects of chronic drug use with a focus on advanced affordable biomolecular and cellular therapies.
-
master’s degree (or equivalent) in Computer Science. have strong computational skills in algorithm design and data analysis. have experience with courses and projects in Bioinformatics. have experience with
-
methods to produce them. Building upon the group’s prior work in this area (millerresearchgroup.co.uk),[8-14 ] this PhD will involve the design and chemoenzymatic synthesis of a new nucleoside and
-
Instituto de Investigação e Inovação em Saúde da Universidade do Porto (i3S) | Portugal | 4 days ago
-00694200, Operation No. 15831 funded by COMPETE2030 and national funds (FCT) under Call No. MPr-2023-12. Scientific Area: Drug delivery systems / Nanomedicine 1. Project summary and work plan GoTOX proposes